Haboub Fadwa, El Fadli Mohamed, Zouiten Othmane, Afani Leila, Belbaraka Rhizlane
Department of Medical Oncology, Centre Hospitalo-Universitaire Mohammed VI, Marrakesh, MAR.
Department of Medical Oncology, Cadi Ayyad University, Marrakesh, MAR.
Cureus. 2025 Jun 15;17(6):e86031. doi: 10.7759/cureus.86031. eCollection 2025 Jun.
Paraneoplastic amyopathic dermatomyositis (ADM) is a rare connective tissue disease presenting with characteristic dermatomyositis-like skin findings in the absence of muscle involvement. It is associated with malignancies in 15%-30% of cases and may portend a fatal outcome, especially when linked to advanced cancers. We report the case of a 58-year-old woman who presented with progressive low back pain and erythroderma. Imaging revealed diffuse bone metastases, and bone biopsy confirmed a poorly differentiated adenocarcinoma of breast origin (estrogen receptor, 60%; progesterone receptor, 35%; GATA3 positive). Simultaneously, dermatological evaluation identified periungual erythema and other cutaneous findings consistent with ADM. The patient was started on endocrine therapy with palbociclib and letrozole, along with corticosteroids and hydroxychloroquine, resulting in partial clinical improvement. However, within six months of diagnosis, she developed severe COVID-19 pneumonia, complicated by pancytopenia and sepsis, and ultimately succumbed to multiorgan failure despite intensive care support. This case underlines the importance of recognizing paraneoplastic ADM as an initial manifestation of malignancy. A multidisciplinary approach is key, but the prognosis largely depends on the cancer's burden and complications such as treatment-induced immunosuppression.
副肿瘤性肌病性皮肌炎(ADM)是一种罕见的结缔组织疾病,在无肌肉受累的情况下出现特征性皮肌炎样皮肤表现。15%-30%的病例与恶性肿瘤相关,可能预示着致命的结局,尤其是与晚期癌症相关时。我们报告了一例58岁女性,她出现进行性腰痛和红皮病。影像学检查发现弥漫性骨转移,骨活检证实为乳腺来源的低分化腺癌(雌激素受体,60%;孕激素受体,35%;GATA3阳性)。同时,皮肤科评估发现甲周红斑和其他符合ADM的皮肤表现。患者开始接受哌柏西利和来曲唑内分泌治疗,同时使用皮质类固醇和羟氯喹,临床症状部分改善。然而,在诊断后的六个月内,她患上了严重的COVID-19肺炎,并发全血细胞减少和败血症,尽管接受了重症监护支持,最终仍死于多器官功能衰竭。该病例强调了认识到副肿瘤性ADM作为恶性肿瘤初始表现的重要性。多学科方法是关键,但预后很大程度上取决于癌症的负担以及诸如治疗引起的免疫抑制等并发症。